首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 製藥 > 骨頭疾病治療 > Forteo:飽和市場中採用劃時代治療方法的個案研究
產業/市場分類
製藥 (4450)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (167)
神經疾病 (175)
骨頭疾病治療 (40)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (316)
精神病 (80)
製藥企業 (500)
糖尿病 (157)
癌症 (837)
藥物開發 (1247)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

Forteo:飽和市場中採用劃時代治療方法的個案研究

Forteo: A Case Study in Launching a Breakthrough Therapy in a Saturated Market

出版商 Decision Resources, Inc.
出版日期 2006年10月 商品編碼 45798
內容資訊 英文 16 Pages
價格
本報告書已不再販售

本報告已在2011年12月21日停止出版。

簡介

骨質疏鬆症市場在2000年以後以年成長率將近20%的比例快速成長,為製藥企業提供了許多的機會。但是實際上卻是由Eli Lilly產品Forteo等幾種藥物主導整個市場。

專門於醫療產業相關廣泛調查的美國市調公司 Decision Resources Inc. (總公司:麻薩諸塞州),針對矚目於Forteo的骨質疏鬆症治療相關個案研究進行調查分析,經糸統整理後出版報告書 "Forteo: A Case Study in Launching a Breakthrough Therapy in a Saturated Market" 。

本報告書內容包括:骨質疏鬆症概要及目前的治療方法、使用的藥物趨勢、Forteo相關發展趨勢及認可、市場參與、包含實際績效的個案研究及從中獲得的教訓等。內容綱要摘記如下:

實施概要

序章

  • 骨質疏鬆症概要
    • 疾病概要、罹患率、經濟負擔
    • 目前的治療方法
      • 雙磷酸鹽(Bisphosphonate)
      • SERM
    • 2005年的骨質疏鬆症市場

個案研究:Forteo

  • Forteo
    • Forteo之發展及認可
    • Forteo進入市場及初期成績
    • Forteo未來發展前景

從Forteo中獲得怎樣的教訓

  • 骨質疏鬆症相關主要治療方法
  • 限制Forteo利用的主要因素

  • 骨質重新形成的結構
  • 骨質重新形成過程中目前的藥物標的
  • 主要藥物分類的市場佔有率:2005年
  • Forteo的各季別銷售成績:2002年∼2006年

目錄

Abstract

Introduction

  • The osteoporosis market has grown near% per year sin00, presenting many
  • opportunities for drug manufacturers. However, several effective, well-established, and
  • reasonably priced agents dominate the market. Even novel therapies satisfying a distinct need
  • face tremendous challenges when launched in this competitive arena.

Get the Answers You Need to Shape Your Strategy

Eli Lilly' s bone-building drug Forteo (teriparatide) was a promising breakthrough treatment for osteoporosis that achieved disappointing sales and relatively low acceptance among patients and physicians. Why did Forteo fail to meet early expectations for its use? Several issues during Forteo' s development phase greatly affected its launch and initial uptake. What are some problems that can hinder the uptake of a breakthrough therapy? What lessons can be learned from Forteo' s development and launch? Even an effective novel agent may face challenges when placed in a market that is saturated with well-established therapies. What factors must drug developers consider when developing and launching new agents?

Scope

  • Overview of osteoporosis: disease description, prevalence, and economic burden.
  • Current market for osteoporosis therapies: overview of common agents used to treat osteoporosis.
  • Case study of Forteo: development and approval, launch and early performance, outlook, lessons to be learned.

Table of Contents

  • Executive Summary
  • Strategic Considerations
  • Stakeholder Implications
  • Introduction
  • An Overview of Osteoporosis
  • Disease Description, Prevalence, and Economic Burden
  • Current Treatments
  • Bisphosphonates
  • SERMs
  • Osteoporosis Mark5
  • Case Study: Forteo
  • Forteo' s Development and Approval
  • Forteo' s Launch and Early Performance
  • The Outlook for Forteo
  • What Can Be Learned from Forteo?

Tables

  • 1. Leading Therapies for the Treatment of Osteoporosis
  • 2. Factors Limiting the Use of Forteo

Figures

  • 1. Diagram of Bone Remodeling
  • 2. Targets for Current Drugs in the Bone Remodeling Process
  • 3. Market Share of Leading Drug Classe05
  • 4. Quarterly Sales of Forte6
Back to Top